Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH (Q61936964)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH |
clinical trial |
Statements
A Phase II Study of Tesetaxel as Second-line Therapy for Subjects With Advanced Melanoma and Normal Serum LDH (English)
0 references
February 2010
0 references
March 2012
0 references
27
0 references
18 year
0 references